Press Release: Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

Dow JonesDec 19 21:30

Express News | Gelteq Appoints DR. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

BreakingsDec 19 21:30

Gelteq Receives FDA Approval of Its Suitability Petition for New Animal Drug

GlobeNewswireDec 17 21:30

Gelteq Limited Shares Halted To The Upside; Stock Now Up 49.44%

BenzingaDec 10 22:42

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

GlobeNewswireDec 9 21:30

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaDec 4 05:05